44 results
Page 2 of 3
8-K
EX-10.3
xk53vflgl
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
v7r1j9e13vt0srpul
14 Jan 22
Prospectus supplement
5:18pm
424B5
lljlhsqy789
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
5a8v3vxy0e
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
1qvsl8zg
22 Nov 21
Definitive proxy
4:37pm
424B5
7pex8i8
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
c5m2a
14 May 21
Quarterly report
4:31pm
10-K
EX-10.1
nso4g6d8smf0
31 Mar 21
Annual report
4:30pm
10-K
j2x3 ti6tr
31 Mar 21
Annual report
4:30pm
S-3
ltoefzf6y4rrodp
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
k46tizmlw2v8wlvw2ub
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.2
kecjqyt
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-10.1
gkj1pp npredni9t191g
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
jni0ve8bsbl1qvm3xzc
2 Nov 20
Prospectus supplement
12:00am